Psychonaut Details Sacred Drug Risks and Revelations

Sacred Drugs: Between Vomiting and Revelation

"I have tried ayahuasca, peyote, San Pedro cactus, and Bufo Alvarius toad secretion." This confession comes not from a weekend urbanite, but from someone who participated in television expeditions, some for RTVE, between the ages of 30 and 40. Their testimony, shared on specialized forums, has peine the debate on psychedelics: are they tools for self-knowledge or simply risky drugs?

The first surprising fact is physical: ingesting these brews causes violent vomiting. "Ayahuasca, peyote, and San Pedro are drunk and taste like shit," he describes. He adds: "The next day you have muscle soreness from vomiting so much." Purging is part of the ritual, but it is not just a side effect: vomiting occurs when the toxin is already in the bloodstream. Music, however, becomes a synesthetic experience: drums are "seen" before the alucinación begins.

Entities and Gods in the Psychedelic Alucinación

Visions are recurrent. The psychonaut recounts encounters with "winged beings in Sumerian/Egyptian style" that communicate telepathically, and conversations with animals such as a snake or a dog. He also claims to have seen "gods and cosmic serpents." But not everything is mysticism: a user with scientific training explains that these entities (surgical mantises, mechanical elves) are innate cognitive modules of the collective unconscious, according to neuroscience. The debate between the spiritual and the materialist runs throughout the conversation.

Safety: ALUCINÓGENO ILEGAL Is Not for Beginners

One of the clearest warnings concerns ALUCINÓGENO ILEGAL. "Above all, don't try it, you could go crazy forever," says the experienced consumer. For those seeking self-discovery, he recommends magic truffles: start with 5 to 10 grams dried. But another participant clarifies: "ALUCINÓGENO ILEGAL has caused fewer overdoses than any recreational drug if taken in the right set and setting." Truffle doses can reach 15 grams for an intense alucinación, and variability between batches is high.

Clinical Application: The Future of Psychiatry?

The thread points to a growing phenomenon: research with psychedelics to treat depression, PTSD, fibromyalgia, or Alzheimer's. According to a participant who identifies as a researcher, laboratories in the US, UK, Australia, and Canada are obtaining "spectacular results" funded by big pharmaceutical industry. However, the psychonaut insists that isolating the active ingredient (like DMT) for recreational use is "a sacrilege": ayahuasca only makes sense within a ritual guided by a shaman.

The testimony leaves a bittersweet aftertaste. Those who have tried these substances claim they "change your way of seeing life forever," but the experience can be terrifying, like that of someone who took a glass full of ayahuasca with rum and felt they were irreversibly dying. Between the promise of expanded consciousness and the risk of a "bad alucinación," the boundary remains blurry. What seems clear is that interest in these sacred drugs continues to grow, both in spiritual circles and in laboratories.